About Acton Pharmaceuticals
Acton Pharmaceuticals is a company based in Marlborough (United States) founded in 2008 was acquired by Meda in August 2013. Acton Pharmaceuticals has raised $36.7 million across 4 funding rounds from investors including Sequoia Capital and Mylan.
- Headquarter Marlborough, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$36.7 M (USD)
in 4 rounds
-
Latest Funding Round
$7 M (USD), Series B
May 13, 2013
-
Investors
Sequoia Capital
& 1 more
-
Employee Count
Not available
-
Acquired by
Meda
(Aug 30, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Acton Pharmaceuticals
Acton Pharmaceuticals has successfully raised a total of $36.7M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acton Pharmaceuticals
Acton Pharmaceuticals has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Sequoia Capital and Mylan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
Mylan, part of Viatris, is focused on healthcare solutions.
|
Locked | Locked | Locked |
Investor details for Acton Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acton Pharmaceuticals
Investment portfolio details for Acton Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acton Pharmaceuticals
Detailed financials for Acton Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acton Pharmaceuticals Comparisons
Peer comparison for Acton Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acton Pharmaceuticals
Detailed competitors of Acton Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acton Pharmaceuticals
Complete news archive for Acton Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acton Pharmaceuticals
Acton Pharmaceuticals was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Acton Pharmaceuticals is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
Acton Pharmaceuticals is a funded company, having raised a total of $36.7M across 4 funding rounds to date.
Acton Pharmaceuticals was established in 2008 in Marlborough, United States, within the pharmaceuticals sector. Focus is placed on developing and commercializing products for respiratory conditions, including generic drugs. Operations center on treatment solutions for such disorders. Acquisition by Meda Pharmaceuticals occurred on August 30, 2013, integrating its activities into the larger entity.
Acton Pharmaceuticals has 2 investors. Key investors include Sequoia Capital, and Mylan.